COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)			10 Months Ended	12 Months Ended
		Aug. 09, 2023	Dec. 31, 2022	Dec. 31, 2023	May 08, 2023	Aug. 09, 2022
Subsidiary, Sale of Stock [Line Items]
Shares issued price per share				$ 1.17
Number of stock issued, value	[1]		$ 25,000
Representative shares issued, value			$ 67,275
Representative shares issued, shares			57,500
Common Class A [Member]
Subsidiary, Sale of Stock [Line Items]
Share price					$ 2.09
Proceeds from initial public offering			$ 115,000,000
Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Share price				0.35
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued price per share				$ 10.25		$ 10.25
Deferred underwriting commission						$ 4,025,000
Representative shares issued, value		$ 67,275
Representative shares issued, shares				57,500
IPO [Member] | Underwriters [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of Class B common stock to Sponsor, shares				1,500,000
Shares issued price per share				$ 10.00
Number of stock issued, value				$ 15,000,000
Share price				$ 0.17
Proceeds from initial public offering				$ 1,955,000
Deferred underwriting commission				$ 4,025,000
IPO [Member] | Underwriters [Member] | Common Class A [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of Class B common stock to Sponsor, shares				57,500

[1] Includes up to 375,000 shares of Class B common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 5). The underwriters exercised their over-allotment option in full on August 9, 2022; thus, no shares of common stock remain subject to forfeiture as of August 9, 2022 (see Note 5).